Back to Search
FREDRICK WIGLEY, M.D.
M.D.
Rheumatology Physician
NPI: 1407891823Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
D21586(MD)
Education
UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Class of 1972
Research & Publications (20)
Systemic sclerosis (scleroderma) is unique among our rheumatic diseases. Preface.
PMID 18329528·Rheum Dis Clin North Am·2008
8-other
The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
PMID 15986394·Arthritis Rheum·2005
4-observational
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
PMID 19643943·Eur Respir J·2010
4-observational
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
PMID 19248104·Arthritis Rheum·2009
4-observational
The "tank top sign": a unique pattern of skin fibrosis seen in pansclerotic morphea.
PMID 19674989·Ann Rheum Dis·2009
5-case
Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
PMID 19333919·Arthritis Rheum·2009
8-other
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
PMID 19333948·Arthritis Rheum·2009
3-trial
Diffuse fasciitis with eosinophilia developing after local irradiation for breast cancer.
PMID 19224125·Clin Rheumatol·2009
5-case
Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.
PMID 19644882·Arthritis Rheum·2009
8-other
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
PMID 19180517·Arthritis Rheum·2009
4-observational
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
PMID 19147617·Ann Rheum Dis·2009
8-other
Fatigue: an overlooked determinant of physical function in scleroderma.
PMID 19106163·Rheumatology (Oxford)·2009
4-observational
Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?
PMID 19568247·Nat Rev Rheumatol·2009
8-other
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
PMID 18957486·Ann Rheum Dis·2009
8-other
Abnormalities in the regulators of angiogenesis in patients with scleroderma.
PMID 19228661·J Rheumatol·2009
8-other
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
PMID 18512816·Arthritis Rheum·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5501 HOPKINS BAYVIEW CIR
BALTIMORE, MD 21224 - Phone
- (410) 550-2400
Quick Facts
- NPI
- 1407891823
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile